most read article

"We Want to Be a Big Fish"

The CDMO (contract development and manufacturing organizations) business has a bright future, of that Siegfried CEO Wolfgang Wienand is certain. The economic advantages alone speak for this compared to in-house production by the pharmaceutical companies themselves. Although Siegfried has already reached sufficient critical size within its industry, he sees the company continuing on its growth path. The goal is to take over an even larger share of the value chain from pharmaceutical companies in the future.

EMA Approves Pfizer-BioNTech Covid Vaccine

The European Medicines Agency (EMA) on Dec. 21 provisionally cleared EU-wide use of the Pfizer-BioNTech Covid-19 vaccine, which will be marketed under the brand name Comirnaty. The Conditional Marketing Authorization paves the way for a rollout across the 27 member states, which is slated to begin by the end of the month and is expected to be a major logistics challenge.

EMA Begins Rolling Review of Molnupiravir

The European Medicines Agency (EMA) has begun a rolling review of US Merck & Co’s oral antiviral molnupiravir as a candidate to treat Covid-19. The EU drugs regulator said it would assess data as soon as it becomes available, before the company submits a formal application containing all the required safety and efficacy data.

Verbio Fokusprojekt biobasierte Chemikalien

Spatenstich im ungarischen Gödöllő für neue Produktionsanlage für Metathese-Katalysatoren der Verbio-Tochter XiMo

Evonik setzt auf Großbatterien

Martina Ludwig wird Kommunikationschefin des VCI